{"id":"NCT01565382","sponsor":"Avid Radiopharmaceuticals","briefTitle":"Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)","officialTitle":"Evaluation of Physician Training for Interpretation of Florbetapir-PET Scans: Evaluation of Inter-reader Reliability Using Images From Subjects With a Clinical Presentation of AD or MCI","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-02","primaryCompletion":"2011-02","completion":"2011-02","firstPosted":"2012-03-28","resultsPosted":"2012-06-27","lastUpdate":"2022-08-16"},"enrollment":40,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"SINGLE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Alzheimer's Disease"],"interventions":[{"type":"DRUG","name":"florbetapir F 18","otherNames":["18F-AV-45","Amyvid","florbetapir"]}],"arms":[{"label":"Independent, blinded reader trainees","type":"EXPERIMENTAL"}],"summary":"Re-read of brain amyloid scans acquired in previous AV-45 clinical studies by readers trained using updated reading methodology. The scans in this study came from subjects who had Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI).","primaryOutcome":{"measure":"Inter-reader Agreement - Median Kappa Statistic","timeFrame":"50-60 min after injection","effectByArm":[{"arm":"A05 Florbetapir-PET Scans","deltaMin":0.72,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}